| |
| |
|
| Insider
Information: |
Shannon Colin |
| Relationship: |
President & CEO, Direc... |
| City: |
New Market Uk |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -36.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmaceutical Product Developme... |
PPDI |
EVP, Global Clinical Ops |
2007-05-04 |
0 |
2004-07-22 |
0 |
Premium* |
|
|
Pra Health Sciences, Inc. |
PRAH |
President & CEO, Direc... |
2021-07-01 |
0 |
2016-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
40 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PPDI |
Pharmaceutical Product De... |
EVP, Global Clinical Ops |
• – – |
2005-07-19 |
4 |
OE |
$28.43 |
$1,124,023 |
D/D |
36,333 |
36,333 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
EVP, Global Clinical Ops |
• – – |
2005-07-19 |
4 |
S |
$59.00 |
$228,153 |
D/D |
(3,867) |
32,466 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
EVP, Global Clinical Ops |
• – – |
2005-07-20 |
4 |
S |
$58.45 |
$1,907,993 |
D/D |
(32,466) |
0 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
EVP, Global Clinical Ops |
• – – |
2006-10-20 |
4 |
OE |
$14.22 |
$1,308,817 |
D/D |
71,167 |
71,167 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
EVP, Global Clinical Ops |
• – – |
2006-10-20 |
4 |
S |
$35.30 |
$2,519,470 |
D/D |
(71,167) |
0 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
EVP, Global Clinical Ops |
• – – |
2007-02-09 |
4 |
S |
$33.97 |
$1,109,499 |
D/D |
(32,500) |
0 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
EVP, Global Clinical Ops |
• – – |
2007-02-09 |
4 |
OE |
$21.19 |
$688,675 |
D/D |
32,500 |
32,500 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
EVP, Global Clinical Ops |
• – – |
2007-05-04 |
4 |
S |
$35.12 |
$339,600 |
D/D |
(9,667) |
0 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
EVP, Global Clinical Ops |
• – – |
2007-05-04 |
4 |
OE |
$15.43 |
$149,162 |
D/D |
9,667 |
9,667 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
EVP, Global Clinical Ops. |
• – – |
2004-07-22 |
4 |
OE |
$21.97 |
$102,978 |
D/D |
4,628 |
4,628 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
EVP, Global Clinical Ops. |
• – – |
2004-07-22 |
4 |
S |
$34.97 |
$161,857 |
D/D |
(4,628) |
0 |
|
- |
|
| PRAH |
Pra Health Sciences, Inc. |
President & CEO |
• • – |
2016-03-02 |
4 |
OE |
$2.94 |
$242,203 |
D/D |
82,382 |
82,382 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
President & CEO |
• • – |
2016-03-02 |
4 |
D |
$45.17 |
$242,247 |
D/D |
(5,363) |
77,019 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
President & CEO |
• • – |
2016-03-08 |
4 |
S |
$42.26 |
$3,254,823 |
D/D |
(77,019) |
0 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
President & CEO |
• • – |
2016-08-18 |
4 |
S |
$51.76 |
$560,147 |
D/D |
(10,822) |
102,311 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
President & CEO |
• • – |
2016-08-18 |
4 |
D |
$51.38 |
$352,826 |
D/D |
(6,867) |
113,133 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
President & CEO |
• • – |
2016-08-18 |
4 |
OE |
$2.94 |
$352,800 |
D/D |
120,000 |
120,000 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
President & CEO |
• • – |
2016-08-19 |
4 |
S |
$51.40 |
$1,012,272 |
D/D |
(19,694) |
82,617 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
President & CEO |
• • – |
2016-08-22 |
4 |
S |
$51.58 |
$4,261,385 |
D/D |
(82,617) |
0 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
President & CEO |
• • – |
2017-02-21 |
4 |
AS |
$61.50 |
$168,941 |
D/D |
(2,747) |
0 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
President & CEO |
• • – |
2017-02-21 |
4 |
OE |
$2.94 |
$8,076 |
D/D |
2,747 |
2,747 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
President & CEO |
• • – |
2017-02-23 |
4 |
OE |
$2.94 |
$285,924 |
D/D |
97,253 |
97,253 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
President & CEO |
• • – |
2017-02-23 |
4 |
AS |
$61.50 |
$5,981,060 |
D/D |
(97,253) |
0 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
President & CEO |
• • – |
2017-03-28 |
4 |
OE |
$2.94 |
$147,000 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
President & CEO |
• • – |
2017-03-28 |
4 |
AS |
$64.00 |
$3,200,000 |
D/D |
(50,000) |
0 |
0 |
- |
|
40 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
